Guest: Charles E. Miller, MD, FACOG Whenever the topic of establishing minimally invasive hysteroscopic surgery in the office setting comes up, many physicians ask why and how. Leveraging decades of professional experience, this activity answers those questions by reviewing the necessary training and staff requirements, the procedures that are most beneficial for your patients, the path to accruing a patient and referral base, and most importantly, maintaining patient safety while ensuring pain control with optimal outcomes. 

Grand Rounds Nation

Establishing an In-Office Minimally Invasive Surgery Practice: Driving Better Patient and Practice Outcomes

Discover how hearing loss in the US is growing and how it affects young and older people alike. Protect your patients' hearing with these tips and resources in an increasingly noisy world from Dr. John Iskander and Dr. William Murphy in this session of Beyond the Data. Visit Dangerousdecibels.org to learn how to protect your hearing. Discover “How loud is too loud?”

Beyond the Data: Hearing Health Across the Lifespan

In this session of Beyond the Data carrying forward ideas discussed at CDC's Public Health Grand Rounds, Dr. Phoebe Thorpe speaks with Dr. Bobbi Pritt, Director of the Clinical Parasitology Laboratory and Co-Director of Vector-borne Diseases Laboratory Services at the Mayo Clinic. The two expand on Dr. Pritt's lecture focusing on advances in diagnosing tickborne diseases.

Beyond the Data: Emerging Tickborne Diseases

In this session of Beyond the Data carrying forward ideas discussed at CDC's Public Health Grand Rounds, Dr. Phoebe Thorpe and Dr. Larry Garber expand on the reasons for medication non-adherence by patients, and priority considerations for helping reduce this risk. 

Beyond the Data: Overcoming Barriers to Medication Adherence for Chronic Diseases

Laboratory safety may sound straightforward, but in reality it is supported by complex and ever-changing science. Safety standards and practices evolve as scientists learn more about the materials they handle regularly. In this session of Public Health Grand Rounds from the CDC, presenters will discuss how standards of laboratory safety have improved over the years, what we’ve learned from past incidents, and how establishing safety protocols and training systems can lead to an overall culture of workplace safety, resulting in continued public trust in our science and recommendations. For more details on this Grand Rounds session and its participants, click here.

Strengthening a Culture of Laboratory Safety

CDC's Dr. Phoebe Thorpe speaks with Dr. Sherif Zaki about the important work being done to further reduce the risk of unusual transplant-associated infections. Ensuring that organs are safe requires: Involvement by many disciplines including: pathologists, epidemiologists, clinicians, and others Global collaboration between federal and state agencies as well as academic institutions Continued focus on improving regulations and screening procedures 

Beyond the Data: Unusual Transplant-Associated Infections -- Just How Unusual?

CDC's Dr. John Iskander and Dr. Janet Wright discuss the progress that has been made with Million Hearts®, along with the work that is still needed to reach the goal of preventing one million heart attacks and strokes by 2017. Providers should: Utilize electronic health records to proactively reach individuals with elevated blood pressure or cholesterol Place emphasis on detecting cases of uncontrolled high blood pressure which are hiding in plain sight Communities can: Implement smoke-free policies to lower exposure to smoke Adopt food procurement policies that make healthier foods more readily available Encourage and train individuals to self-monitor their blood pressure 

Beyond the Data: Preventing A Million Heart Attacks and Strokes

CDC's Dr. Phoebe Thorpe and Dr. David Lakey discuss the many costs of preterm birth, and how we can make prevention a priority in the United States. Tune in to find out how some states, like Texas, are educating the public and taking steps to reduce the rates of preterm birth and infant mortality.

Beyond the Data: Public Health Strategies to Prevent Preterm Birth

Dr. John Iskander and Dr. George Luber revisit their discussion on climate change and its impact on human health to update some of the important new scientific findings that have taken place. Since the first session on climate change: 2014 has been confirmed as the hottest year on record, Extreme climate events are occurring more frequently, and Communities are facing heightened health risks due to drought. 

Beyond the Data: Climate Change and Health – From Science to Practice

Global health security is the protection of the health of people and societies worldwide. With diseases a plane ride or border crossing away, the importance of global health security has never been clearer. Patterns of global travel and trade pose greater opportunities for infectious diseases to emerge and spread nearly anywhere within 24 hours. The Ebola epidemic in West Africa, which has infected more than 28,000 people across 10 countries and has caused more than 11,200 deaths, highlights the importance of ensuring that every country is prepared to prevent, detect, and respond to outbreaks and emerging health threats. In this session of Public Health Grand Rounds from the CDC, experts discuss how CDC, other U.S. government agencies, and global partners are working to promote global health security as an international priority and accelerate progress toward a world safe and secure from epidemics of infectious disease. For more details on this Grand Rounds session and its participants, click here. 

Shifts in Global Health Security: Lessons from Ebola

Host: Matt Birnholz, MD Twenty-five years ago CDC played a pivotal role in the discovery of the virus that causes hepatitis C. After the isolation of HCV, implementation of screening of blood products and organs for donation led to a decrease in rates of HCV infection between 1990 and 2009. In spite of these successes, HCV still remains a serious threat, both domestically and abroad. HCV remains the most common chronic blood borne infection in the United States, affecting approximately 3.9 million individuals. However up to 50% of HCV-infected persons are unaware of their infection. Globally, there are 180 million people who are chronically infected with the virus, and 3-4 million new infections occur every year. Recent therapeutic advances hold the potential to halt the progression of HCV infection and disease. While HCV-infected persons can be effectively treated, more effort is needed to screen, diagnosis, treat and provide continuity of care. This session of Public Health Grand Rounds will discuss how new screening guidelines, testing methods and therapeutic advances will provide us with an opportunity to improve individual outcomes and to eventually eliminate HCV infection. To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/ ...

The 25th Anniversary of the Discovery of the Hepatitis C Virus: Looking Back to Look Forward

Host: Matt Birnholz, MD Tuberculosis is an ancient disease that remains an important global cause of morbidity and mortality. In most cases, TB can be treated and cured by taking a combination of several drugs for 6 to 12 months. When inappropriate or incomplete treatment takes place, however, TB bacteria can develop multidrug resistance (MDR). Annually, there are approximately 500,000 cases of MDR TB, and 150,000 deaths. Although there are simple rapid tests that have improved the diagnosis of the disease, there is immense potential to increase the number of persons diagnosed with MDR TB, and to do so more quickly to initiate treatment sooner. This session of CDC′s Public Health Grand Rounds will explore how more patients can benefit from advances in diagnostic and treatment options, resulting in an overall reduction in morbidity from MDR TB. The role of CDC, WHO and other partners in combating this public health epidemic will also be discussed. To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/

Multidrug-Resistant Tuberculosis: Tackling a New Face of an Old Foe

Host: Matt Birnholz, MD This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease. This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease. This is Part 3 of a lecture in three parts. Part 1 >> Part 2 >> To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/

Reducing the Burden of HPV-associated Cancer & Disease, Part 3

Host: Matt Birnholz, MD This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease. This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease. This is Part 2 of a lecture in three parts. Part 1 >> Part 3 >> To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/

Reducing the Burden of HPV-associated Cancer & Disease, Part 2

Host: Matt Birnholz, MD This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease. This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease. This is Part 1 of a lecture in three parts. Part 2 >> Part 3 >> To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/

Reducing the Burden of HPV-associated Cancer & Disease, Part 1

Grand Rounds, a staple of American medical education for more than 100 years, spans every field of clinical practice. It is a master class on the art and science of medicine, delivered by renowned clinicians in academic settings nationwide. Yet in today's practice, where time is an all-too precious commodity, regular attendance at Grand Rounds sessions has become increasingly difficult. In response to this challenge, ReachMD brings the lecture hall to you, with these outstanding talks from top academic centers across the country.

hubhopper

Grand Rounds Nation

hubhopper